CGNX Stock Analysis: Cognex | NASDAQ
Scientific & Technical Instruments | NASDAQ, USA | Market Cap: 11.283m USD | 12M Return: 99.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 157M
EPS Trend: 48.3%
Qual. Beats: 3
Rev. Trend: 84.8%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cognex Corporation (NASDAQ: CGNX), founded in 1981 and headquartered in Natick, Massachusetts, supplies machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks. The company operates globally, serving customers across the United States, Europe, Greater China, and other international markets. Cognex went public in 1989 and is classified within the Information Technology sector under the Electronic Equipment & Instruments sub-industry.
The companys product portfolio includes its VisionPro vision software, vision systems combining smart cameras with software, and the In-Sight line of vision systems and sensors. It also offers OneVision, a cloud-based platform for building and scaling AI-powered vision applications, along with QuickBuild, a graphical programming interface for vision applications. Cognex sells image-based barcode readers under the DataMan brand and provides vision accessories such as industrial cameras, lenses, and lighting. As a hardware-and-software supplier to industrial automation, Cognexs revenue is closely tied to global capital spending by manufacturers rather than consumer demand directly.
Cognexs products are used to automate tasks such as locating, identifying, inspecting, and measuring discrete items including mobile phones, automotive components, and e-commerce packages. The company serves a diverse set of end markets, including automotive, logistics, packaging, consumer electronics, medical-related, semiconductor, and consumer products industries. This breadth across multiple verticals helps offset cyclicality in any single customer industry, though exposure to automotive and consumer electronics has historically been a meaningful driver of demand.
- Greater China revenue declines on weak smartphone manufacturing demand
- Logistics automation orders slow as e-commerce capex normalizes
- Margins compress on lower volumes and unfavorable product mix
| Net Income: 142.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.61 > 1.0 |
| NWC/Revenue: 46.20% < 20% (prev 42.81%; Δ 3.40% < -1%) |
| CFO/TA 0.12 > 3% & CFO 250.1m > Net Income 142.5m |
| Net Debt (-222.7m) to EBITDA (246.6m): -0.90 < 3 |
| Current Ratio: 3.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (168.4m) vs 12m ago -1.18% < -2% |
| Gross Margin: 68.02% > 18% (prev 68.30%; Δ -0.28% > 0.5%) |
| Asset Turnover: 53.16% > 50% (prev 47.59%; Δ 5.57% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.24 (Total Current Assets 673.1m - Total Current Liabilities 189.5m) / Total Assets 2.01b |
| B: 0.17 (Retained Earnings 344.4m / Total Assets 2.01b) |
| C: 0.11 (EBIT TTM 216.8m / Avg Total Assets 1.97b) |
| D: 2.81 (Book Value of Equity 1.48b / Total Liabilities 526.6m) |
| Altman-Z'' = 5.83 = AAA |
| DSRI: 1.02 (Receivables 190.9m/163.9m, Revenue 1.05b/919.8m) |
| GMI: 1.00 (GM 68.30% / 68.02%) |
| AQI: 0.96 (AQ_t 0.59 / AQ_t-1 0.62) |
| SGI: 1.14 (Revenue 1.05b / 919.8m) |
| TATA: -0.05 (NI 142.5m - CFO 250.1m) / TA 2.01b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of July 13, 2026, the stock is trading at USD 66.80 with a total of 1,692,738 shares traded. Over the past week, the price has changed by -1.47%, over one month by +5.01%, over three months by +22.98% and over the past year by +99.11%.
Current recommended Stop Loss: 60.10 (which is 10% or 1.9 ATR below the current price).
Cognex has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy CGNX.
- StrongBuy: 11
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 77.1 | 15.3% |
P/E Trailing = 79.7647
P/E Forward = 33.8983
P/S = 10.7792
P/B = 7.6314
P/EG = 2.7121
Revenue TTM = 1.05b USD
EBIT TTM = 216.8m USD
EBITDA TTM = 246.6m USD
Long Term Debt = 61.7m USD (estimated: total debt 74.0m - short term 12.3m)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 74.0m USD (from shortLongTermDebtTotal, last quarter) (leases 74.0m already included)
Net Debt = -222.7m USD (calculated: Debt 74.0m - CCE 296.8m)
Enterprise Value = 11.1b USD (11.3b + Debt 74.0m - CCE 296.8m)
Interest Coverage Ratio = unknown (Ebit TTM 216.8m / Interest Expense TTM 0.0)
EV/FCF = 45.87x (Enterprise Value 11.1b / FCF TTM 241.1m)
FCF Yield = 2.18% (FCF TTM 241.1m / Enterprise Value 11.1b)
FCF Margin = 23.03% (FCF TTM 241.1m / Revenue TTM 1.05b)
Net Margin = 13.62% (Net Income TTM 142.5m / Revenue TTM 1.05b)
Gross Margin = 68.02% ((Revenue TTM 1.05b - Cost of Revenue TTM 334.8m) / Revenue TTM)
Gross Margin QoQ = 71.13% (prev 65.75%)
Tobins Q-Ratio = 5.51 (Enterprise Value 11.1b / Total Assets 2.01b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 74.0m)
Taxrate = 34.24% (74.2m / 216.8m)
NOPAT = 142.5m (EBIT 216.8m * (1 - 34.24%))
Current Ratio = 3.55 (Total Current Assets 673.1m / Total Current Liabilities 189.5m)
Debt / Equity = 0.05 (Debt 74.0m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = -0.90 (Net Debt -222.7m / EBITDA 246.6m)
Debt / FCF = -0.92 (Net Debt -222.7m / FCF TTM 241.1m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.24% (Net Income 142.5m / Total Assets 2.01b)
RoE = 9.56% (Net Income TTM 142.5m / Total Stockholder Equity 1.49b)
RoCE = 13.95% (EBIT 216.8m / Capital Employed (Equity 1.49b + L.T.Debt 61.7m))
RoIC = 8.03% (NOPAT 142.5m / Invested Capital 1.78b)
WACC = 12.85% (E(11.3b)/V(11.4b) * Re(12.93%) + D(74.0m)/V(11.4b) * Rd(0.0%) * (1-Tc(0.34)))
Discount Rate = 12.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -1.09%
[DCF] Terminal Value 64.85% ; FCFF base≈209.6m ; Y1≈240.3m ; Y5≈353.7m
[DCF] Fair Price = 19.08 (EV 2.95b - Net Debt -222.7m = Equity 3.18b / Shares 166.4m; r=12.85% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 48.27 | EPS CAGR: 10.99% | SUE: 4.0 | # QB: 3
Revenue Correlation: 84.80 | Revenue CAGR: 6.71% | SUE: 3.77 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.42 | Chg30d=+0.07% | Revisions=+84% | Analysts=18
EPS next Quarter (2026-09-30): EPS=0.37 | Chg30d=+1.29% | Revisions=+40% | Analysts=18
EPS current Year (2026-12-31): EPS=1.48 | Chg30d=+0.38% | Revisions=+40% | GrowthEPS=+44.9% | GrowthRev=+11.4%
EPS next Year (2027-12-31): EPS=1.77 | Chg30d=+0.34% | Revisions=+86% | GrowthEPS=+19.6% | GrowthRev=+8.8%
[Analyst] Revisions Ratio: +93% (up=38, down=0)